Literature DB >> 8205289

Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.

J L Kelsey1, A S Whittemore.   

Abstract

Cancers of the breast, endometrium, and ovary account for 41% of incident cancers among women. Many risk factors for breast cancer have been identified, but most are associated with only modest elevations in risk. Also, of all the risk factors identified, few are likely to be affected by intervention programs. The pathogenesis of breast cancer is not well understood, but estrogen and possibly estrogen plus progesterone are likely to be etiologically involved. For endometrial cancer, a major etiologic pathway is exposure to estrogen without cyclic exposure to progesterone. Most of the established risk factors for endometrial cancer appear to affect risk at least in part through this pathway. Only a few risk factors for ovarian cancer have been identified. The two most commonly suggested etiologic mechanisms for ovarian cancer are (a) that suppression of ovulation reduces risk and (b) that suppression of pituitary gonadotropins reduces risk. Each hypothesis is consistent with some, but not all, of the data. Prospects for the primary prevention of these cancers are discouraging at present because few of the risk factors identified to date are readily subject to modification, especially for breast cancer, and the underlying etiologies of these cancers are not well understood, particularly for breast and ovarian cancers.

Entities:  

Mesh:

Year:  1994        PMID: 8205289     DOI: 10.1016/1047-2797(94)90052-3

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  7 in total

1.  Salpingectomy to prevent ovarian cancer: A Countercurrents Series.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

2.  Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort.

Authors:  Inkyung Baik; Mats Lambe; Qin Liu; Lucy Chie; Sven Cnattingius; Lorelei A Mucci; Tomas Riman; Anders Ekbom; Hans-Olov Adami; Chung-Cheng Hsieh
Journal:  Cancer Causes Control       Date:  2008-05-29       Impact factor: 2.506

Review 3.  Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer.

Authors:  L R Wiseman; K L Goa
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

4.  Identification of sequence polymorphisms in the mitochondrial displacement loop as risk factors for sporadic and familial breast cancer.

Authors:  Meng Cheng; Zhanjun Guo; Haiping Li; Zheng Li; Chunxiao Li; Cuizhi Geng
Journal:  Tumour Biol       Date:  2014-01-16

Review 5.  Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.

Authors:  F Brucker-Davis; K Thayer; T Colborn
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

6.  A population-based cohort study of HRT use and breast cancer in southern Sweden.

Authors:  H Olsson; A Bladström; C Ingvar; T R Möller
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

7.  Intake of dairy products and the risk of breast cancer.

Authors:  P Knekt; R Järvinen; R Seppänen; E Pukkala; A Aromaa
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.